• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单克隆丙种球蛋白病中的浆细胞增殖:与其他生物学变量的关系——诊断及预后意义

Plasma cell proliferation in monoclonal gammopathy: relations with other biologic variables--diagnostic and prognostic significance.

作者信息

Ffrench M, Ffrench P, Remy F, Chapuis-Cellier C, Wolowiec D, Ville D, Bryon P A

机构信息

Laboratoire de Cytologie Analytique, Faculté de Médecine Rockefeller, Lyon, France.

出版信息

Am J Med. 1995 Jan;98(1):60-6. doi: 10.1016/S0002-9343(99)80081-3.

DOI:10.1016/S0002-9343(99)80081-3
PMID:7825620
Abstract

PURPOSE

We investigated the place of direct plasma cell proliferation analysis beside other biologic data in monoclonal gammopathy, particularly the serum level of C-reactive protein (C-RP) PATIENTS: Eighty patients were studied at the time of their diagnosis. Patients with a serum creatinine level greater than 200 mumol/L were excluded.

METHODS

Plasma cell proliferation analysis was performed after bromodeoxyuridine incorporation and double immunoenzymatic labeling on cytological smears, making determination of the plasma cell labeling index (LI) possible. The other biologic variables studied were related to tumor burden (plasmacytosis, hemoglobin, serum levels of monoclonal immunoglobulin, albumin) or to kidney function (creatinine). beta 2-microglobulin (beta 2-M), C-RP, lactic dehydrogenase (LDH), and calcemia were also assessed.

RESULTS

No correlation was found between LI and serum C-RP. LDH was the sole variable significantly correlated to C-RP (P < 0.01). Besides the biologic parameters used for the staging according to the Durie and Salmon classification, beta 2-M, albumin and LI were significantly different between stages (P < 0.0002, < 0.0004, < 0.00001). LDH and C-RP showed no significant difference. Results were similar when patients with and without bone lesions were analyzed separately. Multivariate analysis ranked these variables as follows with respect to prognostic value: beta 2-M, LI, and age.

CONCLUSION

Among the variables analyzed, LI is the sole true reflector of cell proliferation. We confirm its diagnostic and prognostic value.

摘要

目的

我们研究了在单克隆丙种球蛋白病中,直接浆细胞增殖分析在其他生物学数据中的地位,特别是C反应蛋白(C-RP)的血清水平。

患者

80例患者在诊断时接受研究。血清肌酐水平大于200μmol/L的患者被排除。

方法

在溴脱氧尿苷掺入后,对细胞学涂片进行双免疫酶标记,进行浆细胞增殖分析,从而能够测定浆细胞标记指数(LI)。研究的其他生物学变量与肿瘤负荷(浆细胞增多、血红蛋白、单克隆免疫球蛋白血清水平、白蛋白)或肾功能(肌酐)有关。还评估了β2-微球蛋白(β2-M)、C-RP、乳酸脱氢酶(LDH)和血钙。

结果

未发现LI与血清C-RP之间存在相关性。LDH是唯一与C-RP显著相关的变量(P<0.01)。除了根据Durie和Salmon分类用于分期的生物学参数外,β2-M、白蛋白和LI在各期之间存在显著差异(P<0.0002、<0.0004、<0.00001)。LDH和C-RP无显著差异。分别分析有和无骨病变的患者时,结果相似。多变量分析根据预后价值对这些变量进行如下排序:β2-M、LI和年龄。

结论

在所分析的变量中,LI是细胞增殖的唯一真正反映指标。我们证实了其诊断和预后价值。

相似文献

1
Plasma cell proliferation in monoclonal gammopathy: relations with other biologic variables--diagnostic and prognostic significance.单克隆丙种球蛋白病中的浆细胞增殖:与其他生物学变量的关系——诊断及预后意义
Am J Med. 1995 Jan;98(1):60-6. doi: 10.1016/S0002-9343(99)80081-3.
2
[Prognostic analysis and assessment on the clinical staging systems of multiple myeloma--a report of 206 cases].多发性骨髓瘤临床分期系统的预后分析与评估——附206例报告
Ai Zheng. 2006 Apr;25(4):461-4.
3
bcl-2 expression in plasma cells from neoplastic gammopathies and reactive plasmacytosis: a comparative study.肿瘤性丙种球蛋白病和反应性浆细胞增多症中浆细胞的bcl-2表达:一项比较研究
Haematologica. 1998 Apr;83(4):298-304.
4
Staging multiple myeloma patients with active disease using serum levels of beta2m-free HLA class I heavy chain together with IgM or platelet count.利用游离β2微球蛋白的HLA I类重链血清水平以及IgM或血小板计数对活动性疾病的多发性骨髓瘤患者进行分期。
Blood Cells Mol Dis. 2009 Jan-Feb;42(1):71-6. doi: 10.1016/j.bcmd.2008.09.003. Epub 2008 Nov 7.
5
Prognostic factors in multiple myeloma.多发性骨髓瘤的预后因素。
Stem Cells. 1995 Aug;13 Suppl 2:56-63.
6
Time to first disease progression, but not beta2-microglobulin, predicts outcome in myeloma patients who receive thalidomide as salvage therapy.首次疾病进展时间而非β2微球蛋白可预测接受沙利度胺作为挽救治疗的骨髓瘤患者的预后。
Cancer. 2007 Aug 15;110(4):824-9. doi: 10.1002/cncr.22855.
7
[Serum beta 2-microglobulin in multiple myeloma. I. Relation to selected indicators, clinical stage and disease prognosis].[多发性骨髓瘤中的血清β2-微球蛋白。I. 与选定指标、临床分期及疾病预后的关系]
Vnitr Lek. 1991 Apr;37(4):342-51.
8
A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications.多发性骨髓瘤中细胞因子网络综述:诊断、预后及治疗意义
Cancer. 2003 May 15;97(10):2440-52. doi: 10.1002/cncr.11072.
9
Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression.血清胰岛素样生长因子在早期B细胞慢性淋巴细胞白血病患者中并未升高,但仍是疾病进展的一个预后因素。
Eur J Haematol. 2006 Jan;76(1):51-7. doi: 10.1111/j.1600-0609.2005.00553.x.
10
Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma.异常细胞遗传学预示着多发性骨髓瘤患者在接受大剂量治疗和自体血细胞移植后的生存率较低。
Bone Marrow Transplant. 1999 Sep;24(5):497-503. doi: 10.1038/sj.bmt.1701943.

引用本文的文献

1
Comparison of renal function markers in Kuwaiti patients with sickle cell disease.科威特镰状细胞病患者肾功能标志物的比较。
J Clin Pathol. 2006 Apr;59(4):345-51. doi: 10.1136/jcp.2005.026799.